FOCAL-ONSET SEIZURE
Clinical trials for FOCAL-ONSET SEIZURE explained in plain language.
Never miss a new study
Get alerted when new FOCAL-ONSET SEIZURE trials appear
Sign up with your email to follow new studies for FOCAL-ONSET SEIZURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New epilepsy drug shows promise in real-world italian study
Disease control OngoingThis study looks at how cenobamate works in adults whose focal seizures are not controlled by at least two other epilepsy drugs. Researchers will track seizure frequency before and during treatment to see if seizures drop by half or more. The goal is to better understand the drug…
Matched conditions: FOCAL-ONSET SEIZURE
Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A • Aim: Disease control
Last updated May 26, 2026 09:54 UTC
-
New epilepsy drug studied as standalone treatment
Disease control OngoingThis study tests cenobamate, an approved seizure drug, when used by itself in adults with partial-onset epilepsy. About 49 participants will take either 100 mg or 200 mg daily to see if they become seizure-free for 26 weeks. The goal is to gather more data on how well cenobamate …
Matched conditions: FOCAL-ONSET SEIZURE
Phase: PHASE4 • Sponsor: SK Life Science, Inc. • Aim: Disease control
Last updated May 18, 2026 12:10 UTC